Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cytokinetics Inc (CYTK) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cytokinetics Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1061983.
Total stock buying since 2015: $3,409,639.
Total stock sales since 2015: $141,802,280.
Total stock option exercises since 2015: $22,061,108.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 301,628 | $12,455,598 | 87,000 | $1,012,460 |
| 2024 | 0 | $0 | 566,913 | $33,770,931 | 441,385 | $3,574,553 |
| 2023 | 0 | $0 | 336,003 | $12,584,418 | 302,540 | $2,503,702 |
| 2022 | 0 | $0 | 602,547 | $26,510,660 | 622,168 | $5,834,212 |
| 2021 | 0 | $0 | 481,309 | $16,423,971 | 491,287 | $4,201,854 |
| 2020 | 0 | $0 | 1,947,945 | $35,408,116 | 442,810 | $3,361,709 |
| 2019 | 348,072 | $3,280,519 | 64,000 | $656,817 | 0 | $0 |
| 2018 | 0 | $0 | 50,709 | $406,852 | 2,709 | $17,798 |
| 2017 | 0 | $0 | 229,802 | $3,344,442 | 182,703 | $1,417,008 |
| 2016 | 0 | $0 | 5,633 | $69,632 | 0 | $0 |
| 2015 | 21,000 | $129,120 | 21,875 | $170,843 | 21,875 | $137,812 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-09 | 0 | $0 | 13,906 | $686,240 | 0 | $0 |
| 2025-08 | 0 | $0 | 9,000 | $341,400 | 4,000 | $42,400 |
| 2025-07 | 0 | $0 | 19,000 | $683,210 | 4,000 | $42,400 |
| 2025-06 | 0 | $0 | 26,295 | $848,829 | 4,000 | $42,400 |
| 2025-05 | 0 | $0 | 12,456 | $414,690 | 2,000 | $21,200 |
| 2025-04 | 0 | $0 | 35,526 | $1,345,959 | 44,000 | $290,800 |
| 2025-03 | 0 | $0 | 179,445 | $7,848,670 | 23,000 | $509,660 |
| 2025-02 | 0 | $0 | 2,000 | $96,120 | 2,000 | $21,200 |
| 2025-01 | 0 | $0 | 4,000 | $190,480 | 4,000 | $42,400 |
| 2024-12 | 0 | $0 | 175,422 | $8,882,071 | 139,514 | $1,096,638 |
| 2024-11 | 0 | $0 | 24,384 | $1,285,011 | 21,342 | $156,544 |
| 2024-10 | 0 | $0 | 31,352 | $1,665,563 | 25,352 | $192,725 |
| 2024-09 | 0 | $0 | 34,684 | $1,935,708 | 30,600 | $292,476 |
| 2024-08 | 0 | $0 | 36,100 | $1,999,499 | 32,100 | $377,181 |
| 2024-07 | 0 | $0 | 64,353 | $3,617,577 | 42,867 | $414,396 |
| 2024-06 | 0 | $0 | 49,168 | $2,487,193 | 20,722 | $192,147 |
| 2024-04 | 0 | $0 | 43,167 | $3,104,711 | 28,605 | $190,795 |
| 2024-02 | 0 | $0 | 50,105 | $3,928,274 | 46,105 | $296,370 |
| 2024-01 | 0 | $0 | 58,178 | $4,865,324 | 54,178 | $365,281 |
| 2023-12 | 0 | $0 | 24,958 | $1,287,198 | 35,520 | $215,269 |
| 2023-11 | 0 | $0 | 27,500 | $933,000 | 25,000 | $166,750 |
| 2023-10 | 0 | $0 | 40,000 | $1,288,100 | 37,500 | $250,125 |
| 2023-09 | 0 | $0 | 15,000 | $523,362 | 12,500 | $83,375 |
| 2023-08 | 0 | $0 | 46,020 | $1,509,334 | 43,520 | $362,578 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-02 | Harrington Robert Arthur (Director) | Sale | 2,150 | 48.67 | 104,640 |
| 2025-09-02 | Kaye Edward M. Md (Director) | Sale | 6,756 | 50.00 | 337,800 |
| 2025-09-02 | Blum Robert I (President & CEO) | Sale | 5,000 | 48.76 | 243,800 |
| 2025-08-19 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,000 | 38.31 | 76,620 |
| 2025-08-19 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 2,000 | 10.60 | 21,200 |
| 2025-08-15 | Blum Robert I (President & CEO) | Sale | 5,000 | 38.42 | 192,100 |
| 2025-08-05 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,000 | 36.34 | 72,680 |
| 2025-08-05 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 2,000 | 10.60 | 21,200 |
| 2025-07-29 | Blum Robert I (President & CEO) | Sale | 5,000 | 36.45 | 182,250 |
| 2025-07-22 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,000 | 37.47 | 74,940 |
| 2025-07-22 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 2,000 | 10.60 | 21,200 |
| 2025-07-14 | Blum Robert I (President & CEO) | Sale | 5,000 | 38.15 | 190,750 |
| 2025-07-08 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,000 | 33.76 | 67,520 |
| 2025-07-08 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 2,000 | 10.60 | 21,200 |
| 2025-07-01 | Blum Robert I (President & CEO) | Sale | 5,000 | 33.55 | 167,750 |
| 2025-06-17 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,000 | 32.91 | 65,820 |
| 2025-06-17 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 2,000 | 10.60 | 21,200 |
| 2025-06-16 | Blum Robert I (President & CEO) | Sale | 5,000 | 33.80 | 169,000 |
| 2025-06-05 | Callos Andrew (EVP, Chief Commercial Officer) | Sale | 8,659 | 32.04 | 277,434 |
| 2025-06-05 | Kaye Edward M. Md (Director) | Sale | 3,636 | 32.10 | 116,715 |
| 2025-06-03 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,000 | 31.88 | 63,760 |
| 2025-06-03 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 2,000 | 10.60 | 21,200 |
| 2025-06-02 | Blum Robert I (President & CEO) | Sale | 5,000 | 31.22 | 156,100 |
| 2025-05-16 | Blum Robert I (President & CEO) | Sale | 5,000 | 30.93 | 154,650 |
| 2025-05-15 | Bhanji Muna (Director) | Sale | 1,454 | 29.73 | 43,227 |
| 2025-05-06 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,000 | 35.01 | 70,020 |
| 2025-05-06 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 2,000 | 10.60 | 21,200 |
| 2025-05-05 | Callos Andrew (EVP, Chief Commercial Officer) | Sale | 4,002 | 36.68 | 146,793 |
| 2025-04-22 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,000 | 38.11 | 76,220 |
| 2025-04-22 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 2,000 | 10.60 | 21,200 |
| 2025-04-21 | Wierenga Wendall (Director) | Sale | 20,000 | 38.46 | 769,200 |
| 2025-04-21 | Wierenga Wendall (Director) | Option Ex | 20,000 | 6.21 | 124,200 |
| 2025-04-15 | Henderson John T (Director) | Sale | 3,190 | 38.66 | 123,325 |
| 2025-04-15 | Henderson John T (Director) | Option Ex | 20,000 | 6.21 | 124,200 |
| 2025-04-10 | Blum Robert I (President & CEO) | Sale | 5,000 | 36.77 | 183,850 |
| 2025-04-08 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,000 | 36.18 | 72,360 |
| 2025-04-08 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 2,000 | 10.60 | 21,200 |
| 2025-04-07 | Callos Andrew (EVP, Chief Commercial Officer) | Sale | 2,886 | 35.78 | 103,261 |
| 2025-04-03 | Harrington Robert Arthur (Director) | Sale | 450 | 39.43 | 17,743 |
| 2025-03-31 | Blum Robert I (President & CEO) | Sale | 15,000 | 40.75 | 611,250 |
| 2025-03-17 | Callos Andrew (EVP, Chief Commercial Officer) | Sale | 23,675 | 44.76 | 1,066,580 |
| 2025-03-17 | Callos Andrew (EVP, Chief Commercial Officer) | Option Ex | 20,900 | 23.26 | 486,134 |
| 2025-03-17 | Malik Fady Ibraham (EVP Research & Development) | Sale | 4,389 | 44.38 | 194,783 |
| 2025-03-17 | Blum Robert I (President & CEO) | Sale | 37,648 | 44.52 | 1,677,568 |
| 2025-03-14 | Callos Andrew (EVP, Chief Commercial Officer) | Sale | 100 | 45.00 | 4,500 |
| 2025-03-14 | Callos Andrew (EVP, Chief Commercial Officer) | Option Ex | 100 | 23.26 | 2,326 |
| 2025-03-13 | Callos Andrew (EVP, Chief Commercial Officer) | Sale | 26,771 | 43.62 | 1,167,751 |
| 2025-03-06 | Callos Andrew (EVP, Chief Commercial Officer) | Sale | 3,341 | 43.27 | 144,565 |
| 2025-03-06 | Malik Fady Ibraham (EVP Research & Development) | Sale | 8,228 | 43.27 | 356,025 |
| 2025-03-06 | Blum Robert I (President & CEO) | Sale | 16,970 | 43.44 | 737,176 |
| 2025-03-05 | Blum Robert I (President & CEO) | Sale | 25,000 | 43.23 | 1,080,750 |
| 2025-03-04 | Harrington Robert Arthur (Director) | Sale | 900 | 42.50 | 38,250 |
| 2025-03-04 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,000 | 42.50 | 85,000 |
| 2025-03-04 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 2,000 | 10.60 | 21,200 |
| 2025-02-04 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,000 | 48.06 | 96,120 |
| 2025-02-04 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 2,000 | 10.60 | 21,200 |
| 2025-01-21 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,000 | 45.92 | 91,840 |
| 2025-01-21 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 2,000 | 10.60 | 21,200 |
| 2025-01-07 | Malik Fady Ibraham (EVP Research & Development) | Sale | 2,000 | 49.32 | 98,640 |
| 2025-01-07 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 2,000 | 10.60 | 21,200 |
| 2024-12-16 | Wierenga Wendall (Director) | Sale | 742 | 48.61 | 36,068 |
| 2024-12-16 | Wierenga Wendall (Director) | Option Ex | 742 | 7.37 | 5,468 |
| 2024-12-11 | Henderson John T (Director) | Sale | 1,780 | 50.42 | 89,747 |
| 2024-12-11 | Henderson John T (Director) | Option Ex | 11,872 | 7.37 | 87,496 |
| 2024-12-10 | Malik Fady Ibraham (EVP Research & Development) | Sale | 87,600 | 50.64 | 4,436,064 |
| 2024-12-10 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 63,600 | 7.96 | 506,256 |
| 2024-12-02 | Blum Robert I (President & CEO) | Sale | 5,000 | 50.76 | 253,800 |
| 2024-12-02 | Blum Robert I (President & CEO) | Option Ex | 5,000 | 6.67 | 33,350 |
| 2024-11-26 | Malik Fady Ibraham (EVP Research & Development) | Sale | 7,300 | 50.16 | 366,131 |
| 2024-11-26 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 5,300 | 7.96 | 42,188 |
| 2024-11-25 | Wierenga Wendall (Director) | Sale | 742 | 50.00 | 37,100 |
| 2024-11-25 | Wierenga Wendall (Director) | Option Ex | 742 | 7.37 | 5,468 |
| 2024-11-18 | Blum Robert I (President & CEO) | Sale | 5,000 | 50.55 | 252,750 |
| 2024-11-18 | Blum Robert I (President & CEO) | Option Ex | 5,000 | 6.67 | 33,350 |
| 2024-11-12 | Malik Fady Ibraham (EVP Research & Development) | Sale | 6,342 | 58.48 | 370,880 |
| 2024-11-12 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 5,300 | 7.96 | 42,188 |
| 2024-11-01 | Blum Robert I (President & CEO) | Sale | 5,000 | 51.63 | 258,150 |
| 2024-11-01 | Blum Robert I (President & CEO) | Option Ex | 5,000 | 6.67 | 33,350 |
| 2024-10-30 | Malik Fady Ibraham (EVP Research & Development) | Sale | 7,300 | 51.91 | 378,979 |
| 2024-10-30 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 5,300 | 7.96 | 42,188 |
| 2024-10-28 | Wierenga Wendall (Director) | Sale | 4,452 | 52.25 | 232,617 |
| 2024-10-28 | Wierenga Wendall (Director) | Option Ex | 4,452 | 7.37 | 32,811 |
| 2024-10-15 | Malik Fady Ibraham (EVP Research & Development) | Sale | 7,300 | 54.19 | 395,587 |
| 2024-10-15 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 5,300 | 7.96 | 42,188 |
| 2024-10-09 | Blum Robert I (President & CEO) | Sale | 5,000 | 55.61 | 278,050 |
| 2024-10-09 | Blum Robert I (President & CEO) | Option Ex | 5,000 | 6.67 | 33,350 |
| 2024-10-01 | Malik Fady Ibraham (EVP Research & Development) | Sale | 7,300 | 52.10 | 380,330 |
| 2024-10-01 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 5,300 | 7.96 | 42,188 |
| 2024-09-30 | Blum Robert I (President & CEO) | Sale | 5,000 | 52.14 | 260,700 |
| 2024-09-30 | Blum Robert I (President & CEO) | Option Ex | 5,000 | 6.67 | 33,350 |
| 2024-09-17 | Malik Fady Ibraham (EVP Research & Development) | Sale | 7,300 | 56.77 | 414,384 |
| 2024-09-17 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 5,300 | 7.96 | 42,188 |
| 2024-09-16 | Blum Robert I (President & CEO) | Sale | 5,000 | 55.99 | 279,950 |
| 2024-09-16 | Blum Robert I (President & CEO) | Option Ex | 5,000 | 6.67 | 33,350 |
| 2024-09-09 | Parshall B Lynne (Director) | Sale | 5,000 | 54.92 | 274,600 |
| 2024-09-09 | Parshall B Lynne (Director) | Option Ex | 5,000 | 21.61 | 108,050 |
| 2024-09-03 | Malik Fady Ibraham (EVP Research & Development) | Sale | 7,384 | 57.01 | 420,924 |
| 2024-09-03 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 5,300 | 7.96 | 42,188 |
| 2024-09-03 | Blum Robert I (President & CEO) | Sale | 5,000 | 57.03 | 285,150 |
| 2024-09-03 | Blum Robert I (President & CEO) | Option Ex | 5,000 | 6.67 | 33,350 |
| 2024-08-26 | Parshall B Lynne (Director) | Sale | 5,000 | 57.26 | 286,300 |
| 2024-08-26 | Parshall B Lynne (Director) | Option Ex | 5,000 | 21.61 | 108,050 |
| 2024-08-20 | Malik Fady Ibraham (EVP Research & Development) | Sale | 7,300 | 56.24 | 410,588 |
| 2024-08-20 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 5,300 | 7.96 | 42,188 |
| 2024-08-12 | Blum Robert I (President & CEO) | Sale | 11,500 | 55.17 | 634,455 |
| 2024-08-12 | Blum Robert I (President & CEO) | Option Ex | 11,500 | 6.67 | 76,705 |
| 2024-08-12 | Parshall B Lynne (Director) | Sale | 5,000 | 55.20 | 276,000 |
| 2024-08-12 | Parshall B Lynne (Director) | Option Ex | 5,000 | 21.61 | 108,050 |
| 2024-08-07 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 5,300 | 7.96 | 42,188 |
| 2024-08-06 | Malik Fady Ibraham (EVP Research & Development) | Sale | 7,300 | 53.72 | 392,156 |
| 2024-07-30 | Blum Robert I (President & CEO) | Sale | 11,500 | 59.49 | 684,135 |
| 2024-07-30 | Blum Robert I (President & CEO) | Option Ex | 11,500 | 6.67 | 76,705 |
| 2024-07-29 | Parshall B Lynne (Director) | Sale | 5,000 | 59.84 | 299,200 |
| 2024-07-29 | Parshall B Lynne (Director) | Option Ex | 5,000 | 21.61 | 108,050 |
| 2024-07-23 | Malik Fady Ibraham (EVP Research & Development) | Sale | 7,300 | 57.02 | 416,246 |
| 2024-07-23 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 5,300 | 7.96 | 42,188 |
| 2024-07-15 | Parshall B Lynne (Director) | Sale | 5,000 | 55.82 | 279,100 |
| 2024-07-15 | Parshall B Lynne (Director) | Option Ex | 5,000 | 10.68 | 53,400 |
| 2024-07-10 | Blum Robert I (President & CEO) | Sale | 11,500 | 54.29 | 624,335 |
| 2024-07-10 | Blum Robert I (President & CEO) | Option Ex | 5,767 | 6.67 | 38,465 |
| 2024-07-09 | Malik Fady Ibraham (EVP Research & Development) | Sale | 7,300 | 55.90 | 408,070 |
| 2024-07-09 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 5,300 | 7.96 | 42,188 |
| 2024-07-05 | Harrington Robert Arthur (Director) | Sale | 253 | 54.61 | 13,816 |
| 2024-07-01 | Blum Robert I (President & CEO) | Sale | 11,500 | 54.05 | 621,575 |
| 2024-07-01 | Parshall B Lynne (Director) | Sale | 5,000 | 54.22 | 271,100 |
| 2024-07-01 | Parshall B Lynne (Director) | Option Ex | 5,000 | 10.68 | 53,400 |
| 2024-06-25 | Malik Fady Ibraham (EVP Research & Development) | Sale | 7,300 | 53.73 | 392,192 |
| 2024-06-25 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 5,300 | 7.96 | 42,188 |
| 2024-06-17 | Parshall B Lynne (Director) | Sale | 5,000 | 52.55 | 262,750 |
| 2024-06-17 | Parshall B Lynne (Director) | Option Ex | 5,000 | 10.68 | 53,400 |
| 2024-06-11 | Malik Fady Ibraham (EVP Research & Development) | Sale | 7,788 | 53.04 | 413,075 |
| 2024-06-11 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 5,422 | 7.96 | 43,159 |
| 2024-06-04 | Blum Robert I (President & CEO) | Sale | 22,500 | 48.85 | 1,099,125 |
| 2024-06-03 | Harrington Robert Arthur (Director) | Sale | 1,580 | 48.64 | 76,851 |
| 2024-06-03 | Parshall B Lynne (Director) | Sale | 5,000 | 48.64 | 243,200 |
| 2024-06-03 | Parshall B Lynne (Director) | Option Ex | 5,000 | 10.68 | 53,400 |
| 2024-04-25 | Henderson John T (Director) | Sale | 10,562 | 64.54 | 681,671 |
| 2024-04-09 | Malik Fady Ibraham (EVP Research & Development) | Sale | 32,605 | 74.31 | 2,423,040 |
| 2024-04-09 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 28,605 | 6.67 | 190,795 |
| 2024-02-14 | Henderson John T (Director) | Sale | 5,000 | 76.48 | 382,400 |
| 2024-02-14 | Henderson John T (Director) | Option Ex | 5,000 | 4.44 | 22,200 |
| 2024-02-13 | Blum Robert I (President & CEO) | Sale | 12,500 | 76.85 | 960,624 |
| 2024-02-13 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 6.67 | 83,375 |
| 2024-02-06 | Malik Fady Ibraham (EVP Research & Development) | Sale | 32,605 | 79.29 | 2,585,250 |
| 2024-02-06 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 28,605 | 6.67 | 190,795 |
| 2024-01-31 | Blum Robert I (President & CEO) | Sale | 12,500 | 79.57 | 994,624 |
| 2024-01-31 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 6.67 | 83,375 |
| 2024-01-19 | Blum Robert I (President & CEO) | Sale | 12,500 | 81.42 | 1,017,750 |
| 2024-01-19 | Blum Robert I (President & CEO) | Option Ex | 12,500 | 6.67 | 83,375 |
| 2024-01-12 | Henderson John T (Director) | Sale | 5,000 | 85.14 | 425,700 |
Insider trading activities including stock purchases, stock sales, and option exercises of CYTK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cytokinetics Inc (symbol CYTK, CIK number 1061983) see the Securities and Exchange Commission (SEC) website.